Lecamwasam, A.; Ekinci, E.I.; Saffery, R.; Dwyer, K.M.
Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome. Biomedicines 2020, 8, 341.
https://doi.org/10.3390/biomedicines8090341
AMA Style
Lecamwasam A, Ekinci EI, Saffery R, Dwyer KM.
Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome. Biomedicines. 2020; 8(9):341.
https://doi.org/10.3390/biomedicines8090341
Chicago/Turabian Style
Lecamwasam, Ashani, Elif I. Ekinci, Richard Saffery, and Karen M. Dwyer.
2020. "Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome" Biomedicines 8, no. 9: 341.
https://doi.org/10.3390/biomedicines8090341
APA Style
Lecamwasam, A., Ekinci, E. I., Saffery, R., & Dwyer, K. M.
(2020). Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome. Biomedicines, 8(9), 341.
https://doi.org/10.3390/biomedicines8090341